Mogamulizumab Q4week Dosing in Participants With R/R CTCL

Clinical trial NCT04745234 · UNKNOWN

Trial details

NCT number: NCT04745234
Sponsor: Kyowa Kirin, Inc.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Cutaneous T-Cell Lymphoma, Relapsed Cutaneous T-Cell Lymphoma Refractory

Start date: 2021-08-16
Primary completion: 2025-05-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.